Please provide your email address to receive an email when new articles are posted on . Results presented at The Liver Meeting demonstrated 72% of patients achieved a biochemical response after 182 ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. A number of new treatments have become ...

According to the results of a new international study, there may be a role for insulin-like growth factor-binding protein 4 (IGFBP4) in facilitating the interaction between macrophages and injured ...

Sclerosing cholangitis and primary biliary cirrhosis, which is now called primary biliary cholangitis (PBC), are chronic cholestatic liver diseases, but they differ in their causes, affected bile ...

Findings showed a statistically significantly greater proportion of saroglitazar-treated patients achieved a biochemical response vs placebo (treatment difference, 48.5%; P .001). Topline data were ...

UNDERSTANDING PRIMARY BILIARY CHOLANGITIS (PBC): CAUSES, SYMPTOMS, DIAGNOSIS, AND TREATMENT What Causes Primary Biliary Cholangitis?Primary biliary cholangitis (PBC) is a chronic liver disease, and ...

S ince there’s no cure for primary biliary cholangitis (PBC), the main treatment goal is to slow disease progression and ease symptoms, such as itching. The good news is that, for most people, the ...

A major retrospective study shows that people with blood group A face a higher likelihood of autoimmune liver disease, especially primary biliary cholangitis, while those with blood group B appear ...

Patients with primary biliary cholangitis who are treated with the only approved first-line therapy commonly have persistently elevated levels of alkaline phosphatase, bilirubin, or both. New research ...